Neuropsychiatric co-morbidities in non-demented Parkinson′s disease
نویسندگان
چکیده
منابع مشابه
HIV Co-Morbidities and Multi-Morbidities
Several challenges confront those patients living and growing older with HIV disease with regard to non-communicable diseases, including cancer, addictive behaviors, fracture prevalence, heart disease and affective disorders, that present physical and mental health problems among the HIV positive [1-5]. Indeed, frailty and a conglomeration of behavioral risk factors are associated with multisys...
متن کاملImpact of Co-Morbidities in Non Alcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus
Non-alcoholic liver disease(NAFLD) is a common liver disorder which is closely associated with insulin resistance and type 2 diabetes mellitus and it is characterised by fat accumulation in the liver.The prevalence in diabetic population is found to be 20-40%. Studies have shown that NAFLD is strongly associated with severalmetabolic disordersand diseases, such as obesity, type 2 diabetes melli...
متن کاملPsychiatric co-morbidities in Crohn's disease: an often overlooked aspect.
I read with great interest the recent article by Lima et al., 1 Crohn’s diseasemay be associatedwith significant psychiatric illnesses. An incidence rate of depression as high as 32% has been reported in patients with underlying Crohn’s disease.2 Higher degrees of depression are observed in patients with a poor quality of life. Younger individuals with underlying Crohn’s disease are almost 2.75...
متن کاملMisinterpreted neuropsychiatric presentations of medical problems in demented patients.
To the Editor: In a recent issue of the JAOA, Peter Tran, DO, and colleagues1 demonstrate significant associations between neuropsychiatric symptoms and degree of medical illness in patients with dementia. We agree with the authors’ conclusion that recognition of comorbid neuropsychiatric and medical problems is necessary for accurate diagnosis and treatment. We wish to voice our support for th...
متن کاملNon Cognitive Neuropsychiatric Impairments in Alzheimer’s Disease
Methods: 131 patients with AD (mild, moderate degree) were included in the investigation according to the diagnostic criteria of DSM IV and MKB 10. 45 AD patients were on galantamine, 43-memantin and 43-combined therapy. The control group includes 45 patients. In our investigation in the main group of AD patients the duration of the disease was from 6 months to 4.3 years, on average 3.3 years. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Indian Academy of Neurology
سال: 2014
ISSN: 0972-2327
DOI: 10.4103/0972-2327.144287